Are you Dr. Espinosa?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1164 E Home Rd
Ste J
Springfield, OH 45503Phone+1 937-342-9260Fax+1 937-342-9262
Summary
- Dr. Eric Espinosa, MD is a board certified urologist in Springfield, Ohio. He is currently licensed to practice medicine in Ohio and New Hampshire. He is affiliated with Mercy Health - Springfield Regional Medical Center, Soin Medical Center, and Dayton Veterans Affairs Medical Center.
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Urology, 2000 - 2005
The University of Texas Health Science Center at San AntonioClass of 2000
Certifications & Licensure
NH State Medical License 2005 - Present
OH State Medical License 2000 - 2027- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
Publications & Presentations
PubMed
- 273 citationsCentral domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cellsEmma Lefrançais, Anais Duval, Emilie Mirey, Stéphane Roga, Eric Espinosa
Proceedings of the National Academy of Sciences of the United States of America. 2014-10-28 - 76 citationsIL-33 fine tunes mast cell degranulation and chemokine production at the single-cell levelRégis Joulia, Fatima Ezzahra L'Faqihi, Salvatore Valitutti, Eric Espinosa
The Journal of Allergy and Clinical Immunology. 2017-08-01 - 45 citationsNew roles and controls of mast cells.Eric Espinosa, Salvatore Valitutti
Current Opinion in Immunology. 2018-02-01
Press Mentions
BlueWind Medical Brings Revi™ Implantable Tibial Neuromodulation Device to Patients in Central OhioFebruary 8th, 2024- BlueWind Launches Revi Implantable Device in Ohio, USFebruary 9th, 2024
